Lumos: Q2 Earnings Snapshot

August 9, 2022 GMT

AUSTIN, Texas (AP) _ Lumos Pharma, Inc. (LUMO) on Tuesday reported a loss of $7.8 million in its second quarter.

The Austin, Texas-based company said it had a loss of 94 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.

The biopharmaceutical company posted revenue of $403,000 in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LUMO at